Bio Green Med Solution Inc Preferred Stock
BGMSP
BGMSP was delisted on the 20th of March, 2026.
1 hedge funds and large institutions have $3.42K invested in Bio Green Med Solution Inc Preferred Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
5% more capital invested
Capital invested by funds: $3.25K → $3.42K (+$173)
0.01% less ownership
Funds ownership: 0.06% → 0.05% (-0.01%)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$277 |
BGMSP Hedge Fund Activity: Q1 2024 in Review
1 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution Inc Preferred Stock (BGMSP) for Q1 2024, worth a combined $3.42K — up 5.3% from $3.25K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BGMSP and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $277 sold.
- 1 institutional investor held Bio Green Med Solution Inc Preferred Stock (BGMSP) as of Q1 2024, down from 2 in Q4 2023.
- Funds reported $3.42K of Bio Green Med Solution Inc Preferred Stock stock for Q1 2024, up 5.3% quarter-over-quarter.
- 0 funds opened new Bio Green Med Solution Inc Preferred Stock positions in Q1 2024 and 1 closed out, a net change of -1 holder.
- The largest Bio Green Med Solution Inc Preferred Stock seller in Q1 2024 was UBS Group, an estimated $277 sold.
Based on aggregated 13F filings for Q1 2024.